Genincode Share Discussion Threads

[diversification] 23/12/2021 20:24

Mr. T. I envy your entry point. Your entry could be extremely well timed.

[mr. t] 23/12/2021 16:29

I've hopped aboard for the ride here, looks a company with tremendous potential.

[barbello] 23/12/2021 15:38

Finger is on the trigger

[hedgehog 100] 19/12/2021 14:40

Barbello,

I've bought some more already ... couldn't resist it!

[hedgehog 100] 16/12/2021 15:43

Diversification,

You often find that some big trades mark the bottom.

It could well be that someone wanted out this year, preferably ahead of Christmas, and are now done.

[diversification] 15/12/2021 22:06

Can we assume that the seller is finally out? Those are chunky late reported trades and markets look set for a Santa rally! Approx 0.8% of the company traded today with seller not having a declarable interest as I have been assured that institutions are not selling and board are locked in.

[diversification] 15/12/2021 17:35

£15 million above cash value with news flow due. Crazy value. Been busy today and only just seen what’s been happening.

Time to put hand in pocket again.

[hedgehog 100] 15/12/2021 17:20

diversification 10 Sep '21 - 16:52 - 12 of 35 0 1 0
"'@Stifel initiate coverage for @GenIncode with a BUY rating - "With US launch planned for 2022 and potential for sales to reach $225m by 2028E, we see significant upside to the shares." Target price 175p #GENI"

Looks like Christmas has come early this year!

[hedgehog 100] 15/12/2021 17:01

GENI may well be my top share pick for 2022.

Diversification, you said on LSE in September (posting as Diversified) that you expect 145p by the end of the tax year.

Well, I think that 200p by the end of 2022 is possible with the right news, which would be about a six-bagger from the current share price of 33.5p.

[hedgehog 100] 15/12/2021 14:57

At just 33.5p the GENI share price is getting a bit silly now.

The IPO on 22nd. July was at 44p, and that looked a bargain.

Since when there has been steady progress.

I'm a big fan of 'overhang plays', because when the supply of cheap shares dries up, the share price can rebound quite dramatically, which is what I fully expect to happen here.

[diversification] 08/12/2021 21:29

He is locked-in for 12 months. So no new immediate supply of stock from William Rhodes. In fact approx 81.5% of shareholder register are locked in or long term investors.

News is on the horizon at which point we should see a considerable squeeze with a low supply of stock beyond the most recent seller who will at some point be out of stock as they don’t have a declarable position.

50% of market cap unpinned by cash, crazy! But a fantastic opportunity.

[hedgehog 100] 06/12/2021 09:28

29/11/2021 07:00 UK Regulatory (RNS & others) GENinCode PLC Directorate Change LSE:GENI Genincode Plc
"GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces that David Evans, Non-Executive Director, has notified the Board of his intention to stand down from his role with immediate effect.
Bill Rhodes, Non-Executive Chairman of GENinCode Plc said: " We would like to thank David for his invaluable contribution to GENinCode during his tenure. David has worked with members of the GENinCode management team for many years, and he has always provided instrumental strategic advice and counsel from his wealth of experience in the sector. On behalf of the Board, I would like to wish him the very best for the future.""



No I don't think he'll be selling any time soon.

Like most people here I imagine, I think he'll be intending to wait until GENI progresses its business plan, and hopefully multibags, before selling any.

It could be that he always intended stepping down at some point relatively soon after GENI floated, having helped the company achieve this important milestone, and being very busy.

GENI still has five directors, and the board looks very strong.

But the opportunity acquire more cheap GENI shares, with fewer restrictions, could have been an additional inducement.

Either for his own account, and/or for his Intuitive Investments (IIG) life sciences fund.

And investment in GENI from IIG would make perfect sense, and stepping down as a GENI director could simplify this.

[barbello] 06/12/2021 08:45

Bit confused, do you think he is a buyer or seller...my guess is that is is unlikely to do anything and even if he sells at some point its approx £1m worth which out to be easily dealt with at this price (I would certainly top up)

[hedgehog 100] 30/11/2021 17:05

I don't think it's likely that he would try to sell an institutional-sized stake on the market: more likely he would place it, especially with his contacts.

But he's a specialist investor in this sector, so he will know how good GENI is:


He's also extremely wealthy.

So I think it's far more likely that he's become aware of a periodic seller of GENI shares, and wishes to take advantage of that.

[toffeeman] 30/11/2021 16:42

or if he chooses to sell..................

one hell of an overhang

[hedgehog 100] 30/11/2021 14:15

29/11/2021 07:00 UKREG GENinCode PLC Directorate Change
"GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces that David Evans, Non-Executive Director, has notified the Board of his intention to stand down from his role with immediate effect.
Bill Rhodes, Non-Executive Chairman of GENinCode Plc said: " We would like to thank David for his invaluable contribution to GENinCode during his tenure. David has worked with members of the GENinCode management team for many years, and he has always provided instrumental strategic advice and counsel from his wealth of experience in the sector. On behalf of the Board, I would like to wish him the very best for the future.""


David Evans has already been removed from the board of directors page on GENI's website:


He owns 3.46% of GENI's shares:


Now he's resigned he will have more leeway to add to his holding, to take advantage of the depressed GENI s.p.

[hedgehog 100] 25/11/2021 11:09

"The FDA's Breakthrough Devices Program
... Requirements for participation
For a manufacturer to be able to obtain approval for their devices through the Breakthrough Devices Program, it must meet several requirements.
▪ The medical device provides for more effective treatment or diagnosis of life-threatening or irreversibly debilitating human diseases or conditions. Examples would include strokes, heart attacks, cancer, severe trauma and ALS.
▪ At least one of the following criteria must be met:
▪ The device is a technological breakthrough (breakthrough technology). For example, a new genetic test that would allow the treatment options to be evaluated better.
▪ There are no approved alternatives. According to the FDA, there is currently no device that can diagnose Parkinson's disease directly.
▪ It offers a significant improvement compared to approved alternatives.
The device is in the best interest of patients. This would be the case if the alternatives have major side effects or if the new device significantly improves the diagnostic options and their use. ..."


25/11/2021 06:59 UK Regulatory (RNS & others) GENinCode PLC Trading update LSE:GENI Genincode Plc
" ... -- Cardio inCode(R) de-novo submission for US regulatory approval with the FDA - The Company continues to have constructive and ongoing discussions with the FDA and is finalising its de-novo application. The de-novo submission is expected to be filed by the end of this year.
-- Breakthrough Device Designation (FDA) for Cardio inCode(R) - Discussions continue to progress with the FDA to advance Cardio inCode(R) as a 'Breakthrough device'. Discussions have been extended partly due to FDA workload, but also resulting from a detailed assessment of GENinCode's CVD prognostic device which, in turn, has given the Company confidence to file its de-novo submission earlier than it might otherwise have planned. The Company remains well placed to complete this process over the coming months. ..."



The FDA seem to be very seriously considering Cardio inCode(R) for Breakthrough Device Designation.

Which is not surprising, as it appears to meet the qualifying criteria well.

If it gets it, the pathway to approval and sales in the US would clearly be accelerated.

But it would also provide a real boost in terms of kudos and distinction.

[t0pgrader] 25/11/2021 09:15

Seemingly on track

[hedgehog 100] 10/11/2021 14:17

Thanks Toffeeman - good work.

[toffeeman] 10/11/2021 09:49

Hedgehog - thanks for the suggestion - should be there now

[hedgehog 100] 09/11/2021 18:04

Toffeeman,

Thanks for starting this thread.

Please could you add Fundamentals & News to the thread header: you can do this by clicking on edit at the start of your header post above, which will bring up the following boxes which you can click:

Fundamentals News

And also perhaps a link to GENI website (with the HTTP part in upper case to hypertext the link), and some material from it.

Thanks in advance.

[hedgehog 100] 08/11/2021 17:18

A good recent example of spin-out outperformance is BYIT, which IPOed in December at 270p, since when it has doubled.

Current share price 558.5p, market cap. £1.33 billion.

GENI looks to have even more potential though, starting from a much lower market cap., and with such huge business growth prospects.

17/12/2020 08:01 UK Regulatory (RNS & others) Bytes Technology Group PLC Completion of Demerger and Admission to Trading LSE:BYIT Bytes Technology Group Plc
"Following the announcement by Bytes Technology Group on 11 December 2020 of the Offer Price of its IPO, the Company announces the completion of the Demerger of the Bytes Group from the Altron Group, which took effect at 8.00 a.m. (UK time) today.
In addition, the Company announces its entire ordinary share capital consisting of 239,482,333 Ordinary Shares of GBP0.01 each has today been admitted to the premium listing segment of the Official List of the FCA and to trading on the LSE's Main Market for listed securities under the ticker "BYIT" and the Main Board of the JSE by way of a secondary inward listing under the symbol "BYI"."


Bytes Technology (BYIT):